More than 1 in 3 parents reported that their child has dealt with dental problems linked to a lack of routine oral hygiene, ...

The trial of a rural Franklin woman who claimed she is God and the man she killed is Satan concluded Thursday.

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...